-- 根據加拿大皇家銀行資本市場（RBC Capital Markets）週二發布的報告顯示，Ocular Therapeutix (OCUL) 正朝著向美國食品藥品監督管理局（FDA）提交其長效治療濕性年齡相關性黃斑變性藥物axpaxli的上市申請邁進，監管機構已開始就單項試驗審批途徑展開正式討論。 RBC指出，管理層表示，目前正與FDA進行磋商，這使得公司有可能基於其成功的關鍵性研究提交申請，而無需等待預計將於2027年初公佈結果的第二項試驗。 RBC也表示，該公司計劃在6月17日的投資者日活動上提供更多監管和項目的最新進展。 Ocular仍計劃在2027年透過單一試驗審批策略推出axpaxli，RBC重申了其對該藥物「積極的獲益/風險比」的看法。 RBC維持對Ocular股票的「跑贏大盤，投機性風險」評級，目標價為30美元。
Price: $9.84, Change: $+0.13, Percent Change: +1.29%
US equity indexes ended higher on Wednesday, with the S&P 500 and the Nasdaq Composite reaching new highs as the US-Iran closed in on a peace deal and Advanced Micro Devices' (AMD) Q1 results led a rally in semiconductor stocks.* The White House is close to agreeing on a one-page memorandum of understanding to end the war with Iran and set a framework for more detailed negotiations about Tehran's nuclear ambitions, Axios reported, citing two US officials and two other sources briefed on the issue.* Employment in the US private sector grew in April, ADP data showed Wednesday, ahead of nonfarm payrolls due later in the week. Private jobs grew by 109,000, representing the fastest growth pace since January 2025, compared with 120,000 expected in a Bloomberg-compiled survey.* June West Texas Intermediate crude oil fell $7.23 to settle at $95.04 per barrel, while July Brent crude, the global benchmark, was last seen down $8.59 at $101.28.* Advanced Micro Devices shares were up more than 18%, among the top gainers on the S&P 500 and the Nasdaq, after the chipmaker overnight posted stronger-than-expected fiscal Q1 results and issued an upbeat Q2 revenue outlook.* Arista Networks (ANET) shares were down nearly 14%, among the worst S&P 500 performers, after the cloud networking company issued a Q2 revenue outlook late Tuesday slightly below market estimates.
Snap (SNAP) reported a Q1 loss late Wednesday of $0.05 per diluted share, narrowing from the loss of $0.08 a year earlier.Analysts polled by FactSet expected a loss of $0.07.Revenue in the three months ended March 31 rose to $1.53 billion from $1.36 billion a year earlier.Analysts surveyed by FactSet expected $1.53 billion.Snap shares fell 3.8% in after-hours trading.